Journal Article DZNE-2020-04608

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease.

 ;  ;  ;  ;  ;  ;

2015
Rockefeller Univ. Press New York, NY

Journal of experimental medicine 212(11), 1803-1809 () [10.1084/jem.20150478]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Immune cells of myeloid lineage are encountered in the Alzheimer's disease (AD) brain, where they cluster around amyloid-β plaques. However, assigning functional roles to myeloid cell subtypes has been problematic, and the potential for peripheral myeloid cells to alleviate AD pathology remains unclear. Therefore, we asked whether replacement of brain-resident myeloid cells with peripheral monocytes alters amyloid deposition in two mouse models of cerebral β-amyloidosis (APP23 and APPPS1). Interestingly, early after repopulation, infiltrating monocytes neither clustered around plaques nor showed Trem2 expression. However, with increasing time in the brain, infiltrating monocytes became plaque associated and also Trem2 positive. Strikingly, however, monocyte repopulation for up to 6 mo did not modify amyloid load in either model, independent of the stage of pathology at the time of repopulation. Our results argue against a long-term role of peripheral monocytes that is sufficiently distinct from microglial function to modify cerebral β-amyloidosis. Therefore, myeloid replacement by itself is not likely to be effective as a therapeutic approach for AD.

Keyword(s): Alzheimer Disease: metabolism (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Alzheimer Disease: therapy (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Animals (MeSH) ; Brain: metabolism (MeSH) ; Brain: pathology (MeSH) ; Disease Models, Animal (MeSH) ; Female (MeSH) ; Male (MeSH) ; Membrane Glycoproteins: analysis (MeSH) ; Mice (MeSH) ; Mice, Inbred C57BL (MeSH) ; Monocytes: physiology (MeSH) ; Myeloid Cells: physiology (MeSH) ; Receptors, Immunologic: analysis (MeSH) ; Amyloid beta-Peptides ; Membrane Glycoproteins ; Receptors, Immunologic ; Trem2 protein, mouse

Classification:

Contributing Institute(s):
  1. Cell Biology of Neurologic Diseases (AG Jucker)
  2. Experimental neuroimmunology (AG Neher)
Research Program(s):
  1. 342 - Disease Mechanisms and Model Systems (POF3-342) (POF3-342)

Appears in the scientific report 2015
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF >= 10 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > TÜ DZNE > TÜ DZNE-AG Neher (Tübingen)
Document types > Articles > Journal Article
Institute Collections > TÜ DZNE > TÜ DZNE-AG Jucker
Public records
Publications Database

 Record created 2020-02-18, last modified 2024-03-21


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)